Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy
{{output}}
Although pancreatic ductal adenocarcinoma (PDAC) tumors harbor unique intracellular bacteria, therapeutic strategies to harness them and overcome immunotherapy resistance remain elusive. Through 16S rDNA sequencing of PDAC tumors from 40 patients and screening... ...
